Summary for Simple Plex Control for Human CCL16/HCC-4
INTENDED USE AND DESCRIPTION: For use a quantitative control for the determination of human CCL16/HCC-4 concentrations in biological fluids. Controls are supplied lyophilized. Please refer to the lot specific certificate of analysis and Simple Plex Lyophilized Quality Control product insert for additional information.
Human HCC-4, also named NCC-4, liver-expressed chemokine (LEC), and lymphocyte and monocyte chemoattractant (LMC), is a novel CC chemokine identified through bioinformatics. HCC-4 is distantly related to other CC chemokines, exhibiting less than 30% sequence identity. Among these CC chemokines, HCC-4 has the most similarity to HCC-1.
Product Specifications for Simple Plex Control for Human CCL16/HCC-4
Species
Human
Applications
Control, Simple Plex Automated Immunoassay
Source
N/A
Preparation & Storage
Shipping Conditions
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Storage
• Store lyophilized controls at 2-8 °C. Lyophilized controls are stable for up to 12 months from date of receipt. • Reconstituted controls are stable for up to 6 months from date of preparation when stored at ≤ -70 °C. Storage at -20° C is not recommended. • Individual frozen aliquots of low and high controls are designed as single-use entities. Thaw directly before use and discard any remaining volume.
Background: CCL16/HCC-4
Item
Value
Entrez Gene IDs
6360 (Human)
Alternate Names
C-C motif chemokine 16, CCL16, CKb12, Chemokine CC-4, Chemokine LEC, HCC-4, HCC-4Liver-expressed chemokine, HCC4, LCC-1Lymphocyte and monocyte chemoattractant, LEC, LMC, LMCSmall-inducible cytokine A16, Mtn-1, NCC-4, NCC-4ILINCK, NCC4IL-10-inducible chemokine, SCYA16MGC117051, SCYL4, chemokine (C-C motif) ligand 16, liver CC chemokine-1, monotactin-1, new CC chemokine 4, small inducible cytokine subfamily A (Cys-Cys), member 16
Bio-Techne uses cookies to provide you with a great website experience. By continuing to use this website you acknowledge this and agree to our cookie policy. Learn more.